# Enveric Biosciences, Inc.: Form 8-K, filed Sep 1, 2023

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K
- Filed: 2023-09-01
- Accepted by EDGAR: Sep 1, 2023, 17:26 ET
- Period: 2023-09-01
- Accession: 0001493152-23-031526
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000149315223031526/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000149315223031526/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000149315223031526/form8-k.htm

Filed Sep 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-031526. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
